Citations

Clear

6273 citation(s) found for "To, Andrew".

Proteogenomic Re‐Annotation of Coccidioides posadasii Strain Silveira
Mitchell, Natalie M., Sherrard, Andrew L. , Dasari, Surendra , Magee, D. Mitchell, Grys, Thomas E. , Lake, Douglas F. , Grys, Thomas E

Mayo Clinic

PROTEOMICS | November 12, 2017 | Volume: 18 | Issue: 1 | Pages: No page available

10.1002/pmic.201700173 | PMID 29130603 Get It

AbstractThe aims of this study are to provide protein‐based evidence upon which to reannotate the genome of Coccidiodes posadasii, one of two closely related species of Coccidioides, a dimorphic fungal pathogen that causes coccidioidomycosis, also called Valley fever. Proteins present in lysates and filtrates of in vitro grown mycelia and parasitic phase spherules from C. posadasii strain Silveira are analyzed using a GeLC‐MS/MS method. Acquired spectra are processed with a proteogenomics workflow comprising a Silveira proteome database, a six‐frame translation of the Silveira genome and an ab initio gene prediction tool prior to validation against published ESTs. This study provides evidence for 837 genes expressed at the protein level, of which 169 proteins (20.2%) are putative proteins and 103 (12.3%) are not annotated in the Silveira genome. Additionally, 275 novel peptides are derived from intragenic regions of the genome and 13 from intergenic regions, resulting in 172 gene refinements. Additionally, we are the first group to report translationally active retrotransposon elements in a Coccidioides spp. Our study reveals that the currently annotated genome of C. posadasii str. Silveira needs refinement, which is likely to be the case for many nonmodel organisms.
Factors Influencing Squamous Cell Carcinoma In Situ Recurrence and Implications for Treatment Choice
Matsumoto, Andrew , Schmitt, Adam R., Skelley, Logan M., Baum, Christian L.

Mayo Clinic

Dermatologic Surgery | November 7, 2017 | Volume: 44 | Issue: 5 | Pages: 613-620

10.1097/dss.0000000000001400 | PMID 29112529 Get It

BACKGROUND Numerous treatment modalities have been reported for squamous cell carcinoma in situ (SCCIS). Risk factors for recurrence have not been systematically reviewed. OBJECTIVE To systematically review and summarize the data on risk factors that contribute to recurrence of SCCIS. MATERIALS AND METHODS A PubMed search was completed using the terms “SCCIS,” “Bowen's disease,” “Bowen's disease and recurrence,” and “Bowen's disease and Mohs.” These sources were cross-referenced for the terms “treatment,” “management,” “therapy,” “recurrence,” and “margins.” Studies were selected on the basis of relevance and applicable treatments. RESULTS Immunosuppression was the only variable with a statistically signficant association with progression or recurrence of SCCIS. Although there were no data directly correlating subclinical lateral extension or invasive squamous cell carcinoma within SCCIS with recurrence, evidence supports both of these as common features of SCCIS. Other potential recurrence risk factors for which there are limited supporting data included tumor size, depth of follicular extension, and location. CONCLUSION Immunosuppression was the only risk factor associated with increased risk of tumor recurrence. Subclinical tumor extension and occult invasive squamous cell carcinoma are relatively common features that theoretically could increase recurrence risk. These factors should be considered when deciding upon treatment for SCCIS. Further study is required to quantify variables that influence recurrence and to identify optimal treatment options.
Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia
Beam, Elena , Germer, Jeffrey J., Lahr, Brian D. , Yao, Joseph D. , Binnicker, Matthew J. , Lahr, Brian, Yao, Joseph D C, Limper, Andrew Harold, Beam, Elena , Limper, Andrew H. , Razonable, Raymund R.

Mayo Clinic

Clinical Transplantation | November 7, 2017 | Volume: 32 | Issue: 1 | Pages: No page available

10.1111/ctr.13149 | PMID 29112278 Get It

AbstractCytomegalovirus (CMV) pneumonia causes major morbidity and mortality. Its diagnosis requires demonstration of viral cytopathic changes in tissue, entailing risks of lung biopsy. This study aimed to determine CMV viral load (VL) thresholds in bronchoalveolar lavage fluid (BALF) for diagnosis of CMV pneumonia in immunocompromised patients. CMV VL in BALF was studied in 17 patients (83% transplant recipients) and 21 control subjects with and without CMV pneumonia, respectively, using an FDA‐approved PCR assay (Cobas® AmpliPrep/Cobas TaqMan® CMV Test, Roche Molecular Systems, Inc.) calibrated to the WHO International Standard for CMV DNA (NIBSC: 09/162). Receiver operating characteristic curve analysis produced a BALF CMV VL threshold of 34 800, IU/mL with 91.7% sensitivity and 100.0% specificity for diagnosis of possible, probable, and proven CMV pneumonia in transplant patients, while a threshold of 656 000 IU/mL yielded 100% sensitivity and specificity among biopsy‐proven cases. For all immunocompromised patients, a VL threshold of 274 IU/mL was selected. VL thresholds also were normalized to BALF cell count yielding a threshold of 0.32 IU/106 cells with 91.7% sensitivity and 90.5% specificity for possible, probable, and proven CMV pneumonia in transplant recipients. Monitoring CMV VL in BALF may be a less invasive method for diagnosing CMV pneumonia in immunocompromised patients.
Nodular Lymphocyte Predominant Hodgkin Lymphoma of the Ileum
Rangan, Aruna , Grahn, Sarah W., Feldman, Andrew L. , Feldman, Andrew L

Mayo Clinic

Case Reports in Pathology | November 2, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-4

10.1155/2017/5981013 | PMID 29230339 Get It

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma derived from germinal center B lymphocytes that typically presents with localized lymph node involvement and can mimic a variety of both reactive and other neoplastic conditions. Extranodal involvement is uncommon in NLPHL and typically occurs in the context of previously documented or synchronous nodal disease. Involvement of the gastrointestinal tract is exceedingly rare. Here, we present the first case to our knowledge of NLPHL involving the ileum that was discovered incidentally on routine screening colonoscopy in an asymptomatic patient. An awareness of the spectrum of clinical presentations, careful morphologic evaluation, and a comprehensive panel of immunohistochemical stains are essential for correct diagnosis of NLPHL presenting in unusual anatomic sites.
US Internal Medicine Program Director Perceptions of Alignment of Graduate Medical Education and Institutional Resources for Engaging Residents in Quality and Safety
Chacko, Karen M., Halvorsen, Andrew J. , Swenson, Sara, Wahi‐Gururaj, Sandhya , Steinmann, Alwin F., Call, Stephanie, Myers, Jennifer S. , Vidyarthi, Arpana R., Arora, Vineet M.

Mayo Clinic

American Journal of Medical Quality | November 1, 2017 | Volume: 33 | Issue: 4 | Pages: 405-412

10.1177/1062860617739119 | PMID 29090611 Get It

Alignment between institutions and graduate medical education (GME) regarding quality and safety initiatives (QI) has not been measured. The objective was to determine US internal medicine residency program directors’ (IM PDs) perceived resourcing for QI and alignment between GME and their institutions. A national survey of IM PDs was conducted in the Fall of 2013. Multivariable linear regression was used to test association between a novel Integration Score (IS) measuring alignment between GME and the institution via PD perceptions. The response rate was 72.6% (265/365). According to PDs, residents were highly engaged in QI (82%), but adequate funding (14%) and support personnel (37% to 61%) were lower. Higher IS correlated to reports of funding for QI (76.3% vs 54.5%, P = .012), QI personnel (67.3% vs 41.1%, P < .001), research experts (70.5% vs 50.0%, P < .001), and computer experts (69.0% vs 45.8%, P < .001) for QI assistance. Apparent mismatch between GME and institutional resources exists, and the IS may be useful in measuring GME–institutional leadership alignment in QI.
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Chinnaiyan, Prakash , Won, Minhee , Wen, Patrick Y. , Rojiani, Amyn M. , Werner‐Wasik, Maria, Shih, Helen A. , Ashby, Lynn S., Yu, Hsiang-Hsuan Michael, Stieber, Volker W. , Malone, Shawn , Fiveash, John B. , Mohile, Nimish, Ahluwalia, Manmeet S. , Wendland, Merideth M, Stella, Philip J., Kee, Andrew Y., Tsai, Ya-Yu , Shih, Helen A , Wen, Patrick Yung , Mehta, Minesh P. , Ahluwalia, Manmeet S

Mayo Clinic

Neuro-Oncology | October 30, 2017 | Volume: 20 | Issue: 5 | Pages: 666-673

10.1093/neuonc/nox209 | PMID 29126203 Get It

The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis
Puri, Puneet , Liangpunsakul, Suthat , Christensen, Jeffrey E. , Shah, Vijay H. , Kamath, Patrick S. , Katz, Barry P., Yu, Qigui , Kumar, Divya P. , Mirshahi, Faridoddin , Radaeva, Svetlana , Chalasani, Naga , Crabb, David W. , Gores, Gregory J. , Walker, Sue , Comerford, Megan , Borst, Andrew J. , Sanyal, Arun J.

Mayo Clinic

Hepatology | October 30, 2017 | Volume: 67 | Issue: 4 | Pages: 1284-1302

10.1002/hep.29623 | PMID 29083504 Get It

Intestinal dysbiosis is implicated in alcoholic hepatitis (AH). However, changes in the circulating microbiome, its association with the presence and severity of AH, and its functional relevance in AH is unknown. Qualitative and quantitative assessment of changes in the circulating microbiome were performed by sequencing bacterial DNA in subjects with moderate AH (MAH) (n = 18) or severe AH (SAH) (n = 19). These data were compared with heavy drinking controls (HDCs) without obvious liver disease (n = 19) and non–alcohol‐consuming controls (NACs, n = 20). The data were related to endotoxin levels and markers of monocyte activation. Linear discriminant analysis effect size (LEfSe) analysis, inferred metagenomics, and predictive functional analysis using PICRUSt were performed. There was a significant increase in 16S copies/ng DNA both in MAH ( P < 0.01) and SAH ( P < 0.001) subjects. Compared with NACs, the relative abundance of phylum Bacteroidetes was significantly decreased in HDCs, MAH, and SAH ( P < 0.001). In contrast, all alcohol‐consuming groups had enrichment with Fusobacteria ; this was greatest for HDCs and decreased progressively in MAH and SAH. Subjects with SAH had significantly higher endotoxemia ( P = 0.01). Compared with alcohol‐consuming groups, predictive functional metagenomics indicated an enrichment of bacteria with genes related to methanogenesis and denitrification. Furthermore, both HDCs and SAH showed activation of a type III secretion system that has been linked to gram‐negative bacterial virulence. Metagenomics in SAH versus NACs predicted increased isoprenoid synthesis via mevalonate and anthranilate degradation, known modulators of gram‐positive bacterial growth and biofilm production, respectively. Conclusion: Heavy alcohol consumption appears to be the primary driver of changes in the circulating microbiome associated with a shift in its inferred metabolic functions. (H epatology 2018;67:1284‐1302).
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma
Ellin, Fredrik , Srour, Line, Slack, Graham W. , Smedby, Karin E. , Ansell, Stephen M. , Link, Brian K. , Relander, Thomas, Jerkeman, Mats, Connors, Joseph M. , Savage, Kerry J. , Link, Brian K , Maurer, Matthew J. , Jerkeman, Mats , Bennani, N. Nora , Cerhan, James R. , Feldman, Andrew L.

Mayo Clinic

Journal of Clinical Oncology | October 26, 2017 | Volume: 35 | Issue: 36 | Pages: 4019-4026

10.1200/jco.2017.73.8195 | PMID 29072976 Get It

Purpose Peripheral T-cell lymphomas (PTCLs) have aggressive clinical behavior. We have previously shown that event-free survival (EFS) at 24 months (EFS24) is a clinically useful end point in diffuse large B-cell lymphoma. Here, we assess EFS24 and subsequent overall survival (OS) in large, multinational PTCL cohorts. Patients and Methods Patients with systemic PTCL newly diagnosed from 2000 to 2012 and treated with curative intent were included from the United States and Sweden (initial cohorts) and from Canada (replication cohort). EFS was defined as time from date of diagnosis to progression after primary treatment, retreatment, or death. Subsequent OS was measured after achieving EFS24 or from the time of progression if it occurred within 24 months. OS rates were compared with the age-, sex-, and country-matched general population. Results Seven hundred seventy-five patients were included in the study (the median age at diagnosis was 64 years; 63% were men). Results were similar in the initial and replication cohorts, and a combined analysis was undertaken. Sixty-four percent of patients progressed within the first 24 months and had a median OS of only 4.9 months (5-year OS, 11%). In contrast, median OS after achieving EFS24 was not reached (5-year OS, 78%), although relapses within 5 years of achieving EFS24 occurred in 23% of patients. Superior outcomes after achieving EFS24 were observed in younger patients (≤ 60 years of age: 5-year OS, 91%). Conclusion EFS24 stratifies subsequent outcome in PTCL. Patients with PTCL with primary refractory disease or early relapse have extremely poor survival. However, more than one third of patients with PTCL remain in remission 2 years after diagnosis with encouraging subsequent OS, especially in younger patients. These marked differences in outcome suggest that EFS24 has utility for patient counseling, study design, and risk stratification in PTCL.
“Chondroblastoma‐like” epithelioid fibrous histiocytoma: A previously undescribed and potentially confusing variant
Martinez, Anthony P. , Zou, Youran , Billings, Steven D. , Folpe, Andrew L.

Mayo Clinic

Journal of Cutaneous Pathology | October 25, 2017 | Volume: 45 | Issue: 2 | Pages: 99-103

10.1111/cup.13068 | PMID 29068085 Get It

BackgroundEpithelioid benign fibrous histiocytoma has been considered a variant of fibrous histiocytoma, but is now considered a distinct entity, typically showing ALK expression. Most show typical morphological features, including an epidermal collarette and large, bland, epithelioid cells. We have recently encountered 2 examples showing an unusual pattern of pericellular calcification, a previously unreported finding.MethodsAvailable slides were reviewed and clinical follow‐up was obtained.ResultsThese lesions occurred on the chins of a 16‐year‐old and 19‐year‐old female and showed prominent pericellular calcification in addition to otherwise‐typical features of epithelioid fibrous histiocytoma. By immunohistochemistry, both lesions were intensely positive for ALK protein. Clinical follow‐up (available for 1 case) showed the patient to be disease‐free 5 months after excision.ConclusionsTo the best of our knowledge, epithelioid fibrous histiocytomas showing “chondroblastoma‐like” calcification have not been previously reported. The chief significance of this finding seems to be in its potential for confusion with other calcifying tumors of the skin and subcutis. Awareness that epithelioid fibrous histiocytomas may show this unusual morphological finding, careful morphological evaluation and ancillary immunohistochemical studies, including ALK protein, should allow for their confident diagnosis in essentially all instances.
The Southampton Consensus Guidelines for Laparoscopic Liver Surgery
Hilal, Mohammad Abu , Aldrighetti, Luca , Dagher, Ibrahim, Troisi, Roberto , Alikhanov, Ruslan , Aroori, Somaiah , Belli, Giulio, Besselink, Marc G. , Briceño, Javier , Gayet, Brice, D’Hondt, Mathieu , Lesurtel, Mickaël , Menon, Krishna , Lodge, Peter, Rotellar, Fernando , Santoyo, Julio Santoyo , Scatton, Olivier , Sutcliffe, Robert P. , Dam, Ronald M. van , White, Steve, Halls, Mark , Cipriani, Federica , Poel, M. van der, Ciria, Rubén , Barkhatov, Leonid , Gomez-Luque, Yrene, Ocana-Garcia, Sira, Cook, Andrew , Buell, Joseph F. , Clavien, Pierre‐Alain , Dervenis, Christos, Fusai, Giuseppe , Lang, Hauke , Primrose, John , Taylor, Mark , Gulik, Thomas van , Wakabayashi, Go , Asbun, Horacio J. , Cherqui, Daniel , Asbun, Horacio, Ciria, Ruben , Aldrighetti, Luca , Edwin, Bjørn , Besselink, Marc G , Soubrane, Olivier , Poel, Marcel J. van der , Geller, David A. , Rotellar, Fernando , Lesurtel, Mickaël , Cipriani, Federica

Mayo Clinic

Annals of Surgery | October 24, 2017 | Volume: 268 | Issue: 1 | Pages: 11-18

10.1097/sla.0000000000002524 | PMID 29064908 Get It

Objective: The European Guidelines Meeting on Laparoscopic Liver Surgery was held in Southampton on February 10 and 11, 2017 with the aim of presenting and validating clinical practice guidelines for laparoscopic liver surgery. Background: The exponential growth of laparoscopic liver surgery in recent years mandates the development of clinical practice guidelines to direct the speciality's continued safe progression and dissemination. Methods: A unique approach to the development of clinical guidelines was adopted. Three well-validated methods were integrated: the Scottish Intercollegiate Guidelines Network methodology for the assessment of evidence and development of guideline statements; the Delphi method of establishing expert consensus, and the AGREE II-GRS Instrument for the assessment of the methodological quality and external validation of the final statements. Results: Along with the committee chairman, 22 European experts; 7 junior experts and an independent validation committee of 11 international surgeons produced 67 guideline statements for the safe progression and dissemination of laparoscopic liver surgery. Each of the statements reached at least a 95% consensus among the experts and were endorsed by the independent validation committee. Conclusion: The European Guidelines Meeting for Laparoscopic Liver Surgery has produced a set of clinical practice guidelines that have been independently validated for the safe development and progression of laparoscopic liver surgery. The Southampton Guidelines have amalgamated the available evidence and a wealth of experts’ knowledge taking in consideration the relevant stakeholders’ opinions and complying with the international methodology standards.